董事介绍
注:董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Bruce D. Perkins | 男 | Director | 63 | 24.38万美元 | 未持股 | 2017-04-25 |
| Jeffrey A. Rideout | 男 | Director | 55 | 22.71万美元 | 未持股 | 2017-04-25 |
| Jake L. Netterville | 男 | Director | 79 | 25.78万美元 | 未持股 | 2017-04-25 |
| Donald A. Washburn | 男 | Non-executive Chairman | 72 | 30.20万美元 | 未持股 | 2017-04-25 |
| Nathaniel M. Zilkha | 男 | Director | 41 | 24.78万美元 | 未持股 | 2017-04-25 |
| Richard A. Lechleiter | 男 | Director | 58 | 22.81万美元 | 未持股 | 2017-04-25 |
| Julie D. Klapstein | 女 | Director | 62 | 23.11万美元 | 未持股 | 2017-04-25 |
| Paul B. Kusserow | 男 | Director, President and Chief Executive Officer | 55 | 372.01万美元 | 未持股 | 2017-04-25 |
| Linda J. Hall | 女 | Director | 68 | 24.48万美元 | 未持股 | 2017-04-25 |
高管介绍
注:高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| David Kemmerly | 男 | General Counsel | 54 | 未披露 | 未持股 | 2017-04-25 |
| Larry R. Pernosky | 男 | Chief Human Resources Officer | 63 | 96.52万美元 | 未持股 | 2017-04-25 |
| Stephen Seim | 男 | Chief Strategy Officer | 53 | 94.98万美元 | 未持股 | 2017-04-25 |
| Christopher T. Gerard | 男 | Chief Operating Officer | 50 | 未披露 | 未持股 | 2017-04-25 |
| Scott G. Ginn | 男 | Chief Accounting Officer | 48 | 未披露 | 未持股 | 2017-04-25 |
| Michael P. North | 男 | Chief Information Officer | 52 | 未披露 | 未持股 | 2017-04-25 |
| David B. Pearce | 男 | Chief Compliance Officer | 56 | 未披露 | 未持股 | 2017-04-25 |
| Susan Sender | 女 | Chief Clinical Operations Officer | 55 | 未披露 | 未持股 | 2017-04-25 |
| Gary D. Willis | 男 | Chief Financial Officer | 52 | 未披露 | 未持股 | 2017-04-25 |
| Paul B. Kusserow | 男 | Director, President and Chief Executive Officer | 55 | 372.01万美元 | 未持股 | 2017-04-25 |
董事简历
中英对照 |  中文 |  英文- Bruce D. Perkins
-
Bruce D. Perkins是MCCI Group Holdings公司(医生服务公司,总部位于佛罗里达迈阿密,MCCI Group)的战略执行官。2015年1月1日任职MCCI Group之前,他退任Humana公司(任职38年),最近担任Humana公司的医疗保健服务部门的总裁。Once Humana公司拆分其医院业务。期间,他曾担任其区域副总裁兼部门总裁,负责Humana公司在多个市场的健康计划。他曾担任Humana公司的管理团队成员。任职MCCI Group之前,他担任ChenMed公司(位于佛罗里达的多系统运营商,JennCare公司的母公司)的战略顾问兼执行教练。他也任职于the University of Louisville College of Business的咨询委员会。他此前曾担任MCCI Group Holdings公司的董事会主席、Humana Health Plan of Puerto Rico的董事会成员、the American Association of PPOs (AAPPO)的财务主管。
Bruce D. Perkins, the Strategic Executive for MCCI Group Holdings, L.L.C. "MCCI", a physician services company based in Miami, Florida ("MCCI Group"), serves on the boards of three private healthcare companies and is the managing member of the healthcare consulting firm, Perkins, Smith, and Associates. In addition to his MCCI responsibilities, Mr. Perkins serves as a strategic advisor and executive coach for ChenMed, a Florida based MSO, a senior advisor for the Marwood Group, and a senior advisor for US Imaging. He also serves on the Advisory Board of the University of Louisville College of Business and previously served as: chairman of the board of MCCI Group Holdings; a board member of Humana Health Plan of Puerto Rico; treasurer of the American Association of PPOs (AAPPO). Immediately prior to his January 1 2015 employment with MCCI, Mr. Perkins retired from Humana, Inc. ("Humana") after a thirty-eight year career, most recently as President of Humana's Healthcare Services Segment which included the company's pharmacy business, home care business, behavioral health business, physician businesses, and all clinical and provider network functions. Prior to his role as President of Healthcare Services, Mr. Perkins served as Regional Vice President and Divisional President for Humana health plans across multiple markets, and prior to the spin-off Humana's hospital business, Mr. Perkins held multiple leadership positions including Divisional Vice President and hospital CEO, COO, and CFO. - Bruce D. Perkins是MCCI Group Holdings公司(医生服务公司,总部位于佛罗里达迈阿密,MCCI Group)的战略执行官。2015年1月1日任职MCCI Group之前,他退任Humana公司(任职38年),最近担任Humana公司的医疗保健服务部门的总裁。Once Humana公司拆分其医院业务。期间,他曾担任其区域副总裁兼部门总裁,负责Humana公司在多个市场的健康计划。他曾担任Humana公司的管理团队成员。任职MCCI Group之前,他担任ChenMed公司(位于佛罗里达的多系统运营商,JennCare公司的母公司)的战略顾问兼执行教练。他也任职于the University of Louisville College of Business的咨询委员会。他此前曾担任MCCI Group Holdings公司的董事会主席、Humana Health Plan of Puerto Rico的董事会成员、the American Association of PPOs (AAPPO)的财务主管。
- Bruce D. Perkins, the Strategic Executive for MCCI Group Holdings, L.L.C. "MCCI", a physician services company based in Miami, Florida ("MCCI Group"), serves on the boards of three private healthcare companies and is the managing member of the healthcare consulting firm, Perkins, Smith, and Associates. In addition to his MCCI responsibilities, Mr. Perkins serves as a strategic advisor and executive coach for ChenMed, a Florida based MSO, a senior advisor for the Marwood Group, and a senior advisor for US Imaging. He also serves on the Advisory Board of the University of Louisville College of Business and previously served as: chairman of the board of MCCI Group Holdings; a board member of Humana Health Plan of Puerto Rico; treasurer of the American Association of PPOs (AAPPO). Immediately prior to his January 1 2015 employment with MCCI, Mr. Perkins retired from Humana, Inc. ("Humana") after a thirty-eight year career, most recently as President of Humana's Healthcare Services Segment which included the company's pharmacy business, home care business, behavioral health business, physician businesses, and all clinical and provider network functions. Prior to his role as President of Healthcare Services, Mr. Perkins served as Regional Vice President and Divisional President for Humana health plans across multiple markets, and prior to the spin-off Humana's hospital business, Mr. Perkins held multiple leadership positions including Divisional Vice President and hospital CEO, COO, and CFO.
- Jeffrey A. Rideout
-
Jeffrey A. Rideout,是the Integrated Healthcare Association(加州全州多方利益相关者的领导组织,从事促进卫生保健的质量改进、责任和负担能力)的总裁兼首席执行官。他于2015年5月加入Integrated Healthcare Association。他也曾担任GE Healthcare Ventures公司的高级顾问(2014年3月以来),专注于数字健康和数字疗法有关新业务开发,包括评估和加速新早期解决方案和公司。他曾担任Stanford University(2014年1月以来)、University of California Berkeley Haas School of Business(2008年1月以来,2002年1月至2004年1月)的学术职务,教医疗技术、服务和投资相关主题。此前,他曾担任Covered California(加州保险交易所)的高级医疗顾问(2013年6月至2015年6月),负责质量和网络管理,以及所有医生和医院的关系。2009年7月至2013年6月,他曾担任The TriZetto Group的高级副总裁、首席医疗官,领导一套全面的产品和服务的战略开发和交付,使纳税人、供应商和雇主能够改善消费者的护理的成本和质量。他也曾担任Cisco Systems Internet Business Solutions Group、Cisco’s Chief Medical Officer医疗保健部门的全球领导人。任职Cisco公司期间,他也曾担任美国卫生和人类服务部(the US Department of Health and Human Services)的美国卫生信息社区(AHIC)慢性保健工作集团(the American Health Information Community (AHIC’s) Chronic Care Workgroup)的成员。他曾任职Cisco公司(从2004年4月到2007年8月)。任职Cisco公司之前,他曾担任Blue Shield of California Foundation的总裁兼首席执行官、Blue Shield of California的首席医疗官和高级副总裁,以及Blue Cross of California/WellPoint的质量管理主管。他目前是Contra Costa Interfaith Housing(为加利福尼亚柯斯县的低收入家庭提供永久住房)的董事会主席。他也是Medical Teams International(国际医疗救援组织,位于俄勒冈州的波特兰市)的14年董事会成员和志愿者。他完成了加利福尼亚大学旧金山分校(University of California, San Francisco)的内科住院医师培训,也是the American College of Physicians的成员。他持有Harvard Medical School的医学学位,以及Stanford University的学士学位。他持有Oxford University的哲学、政治学和经济学硕士学位,在那里他曾担任罗兹学者。
Jeffrey A. Rideout is President and Chief Executive Officer of the Integrated Healthcare Association, a California statewide multi-stakeholder leadership group that promotes quality improvement, accountability and affordability of health care. He joined Integrated Healthcare Association in May of 2015. Dr. Rideout has also served as a Senior Advisor to GE Healthcare Ventures since March 2014 focusing on new business development related to Digital Health and Digital Therapeutics, including assessing and accelerating new early stage solutions and companies. Dr. Rideout holds academic appointments with Stanford University since January 2014 and University of California Berkeley Haas School of Business (since January 2008 and previously from January 2002 to January 2004), teaching on topics related to healthcare technology, services and investment. Previously, from June 2013 until June 2015 Dr. Rideout served as the Senior Medical Advisor for Covered California, the state based insurance exchange for California, and was responsible for quality and network management and all physician and hospital relations. From July 2009 until June 2013 Dr. Rideout was Senior Vice President, Chief Medical Officer for The TriZetto Group, leading strategy around development and delivery of a comprehensive suite of products and services that enable payers, providers and employers improve the cost and quality of care for consumers. Dr. Rideout also served as the global leader of the healthcare division for Cisco Systems Internet Business Solutions Group, and Cisco’s Chief Medical Officer. While at Cisco, Dr. Rideout also served as a member of the American Health Information Community (AHIC’s) Chronic Care Workgroup for the US Department of Health and Human Services. Dr. Rideout was at Cisco from April 2004 to August 2007. Prior to Cisco, Dr. Rideout was President and CEO of Blue Shield of California Foundation, Chief Medical Officer and SVP for Blue Shield of California and head of Quality Management for Blue Cross of California/WellPoint. Dr. Rideout currently serves on the board of directors of MatrixCare, a provider of technology solutions for skilled nursing and senior living providers, life plan communities (CCRCs), and home health organizations. Dr. Rideout is currently board chair for Contra Costa Interfaith Housing, which provides permanent housing to low income families in Contra Costa County, California. He is also a 14 year board member and volunteer for Medical Teams International, an international medical relief organization based in Portland, Oregon. Dr. Rideout completed his residency training in internal medicine at University of California, San Francisco and is a Fellow of the American College of Physicians. He received his medical degree from Harvard Medical School and his undergraduate degree from Stanford University. He also holds a master’s degree in Philosophy, Politics, and Economics from Oxford University where he studied as a Rhodes Scholar. - Jeffrey A. Rideout,是the Integrated Healthcare Association(加州全州多方利益相关者的领导组织,从事促进卫生保健的质量改进、责任和负担能力)的总裁兼首席执行官。他于2015年5月加入Integrated Healthcare Association。他也曾担任GE Healthcare Ventures公司的高级顾问(2014年3月以来),专注于数字健康和数字疗法有关新业务开发,包括评估和加速新早期解决方案和公司。他曾担任Stanford University(2014年1月以来)、University of California Berkeley Haas School of Business(2008年1月以来,2002年1月至2004年1月)的学术职务,教医疗技术、服务和投资相关主题。此前,他曾担任Covered California(加州保险交易所)的高级医疗顾问(2013年6月至2015年6月),负责质量和网络管理,以及所有医生和医院的关系。2009年7月至2013年6月,他曾担任The TriZetto Group的高级副总裁、首席医疗官,领导一套全面的产品和服务的战略开发和交付,使纳税人、供应商和雇主能够改善消费者的护理的成本和质量。他也曾担任Cisco Systems Internet Business Solutions Group、Cisco’s Chief Medical Officer医疗保健部门的全球领导人。任职Cisco公司期间,他也曾担任美国卫生和人类服务部(the US Department of Health and Human Services)的美国卫生信息社区(AHIC)慢性保健工作集团(the American Health Information Community (AHIC’s) Chronic Care Workgroup)的成员。他曾任职Cisco公司(从2004年4月到2007年8月)。任职Cisco公司之前,他曾担任Blue Shield of California Foundation的总裁兼首席执行官、Blue Shield of California的首席医疗官和高级副总裁,以及Blue Cross of California/WellPoint的质量管理主管。他目前是Contra Costa Interfaith Housing(为加利福尼亚柯斯县的低收入家庭提供永久住房)的董事会主席。他也是Medical Teams International(国际医疗救援组织,位于俄勒冈州的波特兰市)的14年董事会成员和志愿者。他完成了加利福尼亚大学旧金山分校(University of California, San Francisco)的内科住院医师培训,也是the American College of Physicians的成员。他持有Harvard Medical School的医学学位,以及Stanford University的学士学位。他持有Oxford University的哲学、政治学和经济学硕士学位,在那里他曾担任罗兹学者。
- Jeffrey A. Rideout is President and Chief Executive Officer of the Integrated Healthcare Association, a California statewide multi-stakeholder leadership group that promotes quality improvement, accountability and affordability of health care. He joined Integrated Healthcare Association in May of 2015. Dr. Rideout has also served as a Senior Advisor to GE Healthcare Ventures since March 2014 focusing on new business development related to Digital Health and Digital Therapeutics, including assessing and accelerating new early stage solutions and companies. Dr. Rideout holds academic appointments with Stanford University since January 2014 and University of California Berkeley Haas School of Business (since January 2008 and previously from January 2002 to January 2004), teaching on topics related to healthcare technology, services and investment. Previously, from June 2013 until June 2015 Dr. Rideout served as the Senior Medical Advisor for Covered California, the state based insurance exchange for California, and was responsible for quality and network management and all physician and hospital relations. From July 2009 until June 2013 Dr. Rideout was Senior Vice President, Chief Medical Officer for The TriZetto Group, leading strategy around development and delivery of a comprehensive suite of products and services that enable payers, providers and employers improve the cost and quality of care for consumers. Dr. Rideout also served as the global leader of the healthcare division for Cisco Systems Internet Business Solutions Group, and Cisco’s Chief Medical Officer. While at Cisco, Dr. Rideout also served as a member of the American Health Information Community (AHIC’s) Chronic Care Workgroup for the US Department of Health and Human Services. Dr. Rideout was at Cisco from April 2004 to August 2007. Prior to Cisco, Dr. Rideout was President and CEO of Blue Shield of California Foundation, Chief Medical Officer and SVP for Blue Shield of California and head of Quality Management for Blue Cross of California/WellPoint. Dr. Rideout currently serves on the board of directors of MatrixCare, a provider of technology solutions for skilled nursing and senior living providers, life plan communities (CCRCs), and home health organizations. Dr. Rideout is currently board chair for Contra Costa Interfaith Housing, which provides permanent housing to low income families in Contra Costa County, California. He is also a 14 year board member and volunteer for Medical Teams International, an international medical relief organization based in Portland, Oregon. Dr. Rideout completed his residency training in internal medicine at University of California, San Francisco and is a Fellow of the American College of Physicians. He received his medical degree from Harvard Medical School and his undergraduate degree from Stanford University. He also holds a master’s degree in Philosophy, Politics, and Economics from Oxford University where he studied as a Rhodes Scholar.
- Jake L. Netterville
-
Jake L. Netterville,他从1977年到1998年是Postlethwaite & Netterville的管理合伙人,一家专业会计公司。目前是它的董事会的名誉主席。他是一个注册会计师,曾担任美国注册会计师协会有限公司董事会主席,管理委员会常任理事成员。他在2003年2月被任命为审计委员会的董事会主席。
Jake L. Netterville was the Managing Partner of Postlethwaite & Netterville, a professional accounting corporation, from 1977 to 1998 and is currently the Chairman, Emeritus, of its Board of Directors. Mr. Netterville is a certified public accountant, has served as Chairman of the Board of Directors of the American Institute of Certified Public Accountants, Inc. “AICPA” and is a permanent member of the AICPA’s Governing Council. Mr. Netterville was appointed Chairman of the Audit Committee of our Board of Directors in February 2003. - Jake L. Netterville,他从1977年到1998年是Postlethwaite & Netterville的管理合伙人,一家专业会计公司。目前是它的董事会的名誉主席。他是一个注册会计师,曾担任美国注册会计师协会有限公司董事会主席,管理委员会常任理事成员。他在2003年2月被任命为审计委员会的董事会主席。
- Jake L. Netterville was the Managing Partner of Postlethwaite & Netterville, a professional accounting corporation, from 1977 to 1998 and is currently the Chairman, Emeritus, of its Board of Directors. Mr. Netterville is a certified public accountant, has served as Chairman of the Board of Directors of the American Institute of Certified Public Accountants, Inc. “AICPA” and is a permanent member of the AICPA’s Governing Council. Mr. Netterville was appointed Chairman of the Audit Committee of our Board of Directors in February 2003.
- Donald A. Washburn
-
Donald A. Washburn自2004年8月以来是董事会成员。他是私人投资者。他从1995年到1998年担任国际航空公司Northwest Airlines, Inc.运营部的执行副总裁。从1997年到1998年他担任Northwest Cargo的主席和总裁。成为执行副总裁之前,他从1990年到1995年是Northwest Airlines, Inc.的高级副总裁。他从1980年到1990年在国际酒店公司Marriott Corporation担任数个职位,最近担任的是执行副总裁。他同时还担任Amedisys,Inc.的董事长,LaSalle Hotel Properties的理事,Key Technology, Inc.以及私营公司和非盈利企业的董事。他以优等成绩获得芝加哥罗耀拉大学(Loyola University of Chicago)的学士学位,西北大学凯洛格管理学院(Northwestern University's Kellogg School of Management)的工商管理硕士学位,以优等成绩获得西北大学法学院(Northwestern University's School of Law)的法学博士学位。他在哈佛大学商学院(Harvard Business School),斯坦福大学法学院(Stanford Law School),凯洛格管理学院(Kellogg School of Management),宾夕法尼亚大学沃顿商学院(Wharton Business School at the University of Pennsylvania)和行业研讨会(包括Boardroom Summit和Stanford Director's College)继续商业和法律专业教育。
Donald A. Washburn has served as a member of the Board since 2004. Mr. Washburn is a private investor. Mr. Washburn served as Executive Vice President of Operations of Northwest Airlines, Inc., an international airline, from 1995 to 1998. Mr. Washburn also served as Chairman and President of Northwest Cargo from 1997 to 1998. Prior to becoming Executive Vice President, he served as Senior Vice President for Northwest Airlines, Inc. from 1990 to 1995. Mr. Washburn served in several positions from 1980 to 1990 for Marriott Corporation, an international hospitality company, most recently as Executive Vice President. He also previously served on the boards of Key Technology, Inc. and Amedisys, Inc., and served as a trustee of LaSalle Hotel Properties as well as privately held companies and non-profit corporations. Mr. Washburn received his BBA, cum laude, from Loyola University of Chicago, an MBA from Northwestern University's Kellogg School of Management and a J.D., cum laude, from Northwestern University's Pritzker School of Law. He has continued his professional education in business and law attending Harvard Business School, Stanford Law School, Kellogg School of Management, Wharton Business School at the University of Pennsylvania and industry seminars, including the Boardroom Summit and Stanford Director's College. - Donald A. Washburn自2004年8月以来是董事会成员。他是私人投资者。他从1995年到1998年担任国际航空公司Northwest Airlines, Inc.运营部的执行副总裁。从1997年到1998年他担任Northwest Cargo的主席和总裁。成为执行副总裁之前,他从1990年到1995年是Northwest Airlines, Inc.的高级副总裁。他从1980年到1990年在国际酒店公司Marriott Corporation担任数个职位,最近担任的是执行副总裁。他同时还担任Amedisys,Inc.的董事长,LaSalle Hotel Properties的理事,Key Technology, Inc.以及私营公司和非盈利企业的董事。他以优等成绩获得芝加哥罗耀拉大学(Loyola University of Chicago)的学士学位,西北大学凯洛格管理学院(Northwestern University's Kellogg School of Management)的工商管理硕士学位,以优等成绩获得西北大学法学院(Northwestern University's School of Law)的法学博士学位。他在哈佛大学商学院(Harvard Business School),斯坦福大学法学院(Stanford Law School),凯洛格管理学院(Kellogg School of Management),宾夕法尼亚大学沃顿商学院(Wharton Business School at the University of Pennsylvania)和行业研讨会(包括Boardroom Summit和Stanford Director's College)继续商业和法律专业教育。
- Donald A. Washburn has served as a member of the Board since 2004. Mr. Washburn is a private investor. Mr. Washburn served as Executive Vice President of Operations of Northwest Airlines, Inc., an international airline, from 1995 to 1998. Mr. Washburn also served as Chairman and President of Northwest Cargo from 1997 to 1998. Prior to becoming Executive Vice President, he served as Senior Vice President for Northwest Airlines, Inc. from 1990 to 1995. Mr. Washburn served in several positions from 1980 to 1990 for Marriott Corporation, an international hospitality company, most recently as Executive Vice President. He also previously served on the boards of Key Technology, Inc. and Amedisys, Inc., and served as a trustee of LaSalle Hotel Properties as well as privately held companies and non-profit corporations. Mr. Washburn received his BBA, cum laude, from Loyola University of Chicago, an MBA from Northwestern University's Kellogg School of Management and a J.D., cum laude, from Northwestern University's Pritzker School of Law. He has continued his professional education in business and law attending Harvard Business School, Stanford Law School, Kellogg School of Management, Wharton Business School at the University of Pennsylvania and industry seminars, including the Boardroom Summit and Stanford Director's College.
- Nathaniel M. Zilkha
-
Nathaniel M. Zilkha,2007年10月以来,他担任我们的董事会成员。2004年以来,他在KKR任职,他是其特殊情况投资全球联合负责人,包括公司的公共和私人不良和结构化投资活动。他此前担任KKR的北美私人股本公司成员。KKR的附属基金会是我们公司的最大股东。加入KKR之前,他在高盛投资公司(Goldman Sachs)主要投资领域任职8年,他对私人股本和债务交易进行投资。他毕业于普林斯顿大学(Princeton University)。作为KKR的员工,他为董事会带来了主要债务交易和医疗行业公司工作的经验。
Nathaniel M. Zilkha is a Member of KKR Management LLC, which is the general partner of KKR & Co. L.P. together with its affiliates, “KKR”. Mr. Zilkha joined KKR in 2007 and serves as the Co-Head of KKR Credit, KKR’s global credit investing business. KKR Credit invests in special situations, private credit and leveraged credit (long only, opportunistic and long/short traded credit), primarily through private funds, separate accounts and CLO’s. He is also the co-portfolio manager of the KKR Special Situations funds, which he has managed since their inception in 2009. He is a member of the Private Credit Investment Committee, Special Situations Investment Committee, Credit Portfolio Management Committee and Public Markets Management Committee. Mr. Zilkha also spent time as a member of KKR’s Private Equity Team in KKR’s Menlo Park office. Prior to joining KKR, Mr. Zilkha was a member of the Principal Investment Area of Goldman, Sachs & Co., where he invested in private equity and principal debt transactions. He is currently on the boards of directors of Amedisys, QMH, and Winoa. At KKR, he was formerly on the boards of Harden Healthcare, Oriental Brewery, and Jazz Pharmaceuticals. Mr. Zilkha graduated cum laude from Princeton University. - Nathaniel M. Zilkha,2007年10月以来,他担任我们的董事会成员。2004年以来,他在KKR任职,他是其特殊情况投资全球联合负责人,包括公司的公共和私人不良和结构化投资活动。他此前担任KKR的北美私人股本公司成员。KKR的附属基金会是我们公司的最大股东。加入KKR之前,他在高盛投资公司(Goldman Sachs)主要投资领域任职8年,他对私人股本和债务交易进行投资。他毕业于普林斯顿大学(Princeton University)。作为KKR的员工,他为董事会带来了主要债务交易和医疗行业公司工作的经验。
- Nathaniel M. Zilkha is a Member of KKR Management LLC, which is the general partner of KKR & Co. L.P. together with its affiliates, “KKR”. Mr. Zilkha joined KKR in 2007 and serves as the Co-Head of KKR Credit, KKR’s global credit investing business. KKR Credit invests in special situations, private credit and leveraged credit (long only, opportunistic and long/short traded credit), primarily through private funds, separate accounts and CLO’s. He is also the co-portfolio manager of the KKR Special Situations funds, which he has managed since their inception in 2009. He is a member of the Private Credit Investment Committee, Special Situations Investment Committee, Credit Portfolio Management Committee and Public Markets Management Committee. Mr. Zilkha also spent time as a member of KKR’s Private Equity Team in KKR’s Menlo Park office. Prior to joining KKR, Mr. Zilkha was a member of the Principal Investment Area of Goldman, Sachs & Co., where he invested in private equity and principal debt transactions. He is currently on the boards of directors of Amedisys, QMH, and Winoa. At KKR, he was formerly on the boards of Harden Healthcare, Oriental Brewery, and Jazz Pharmaceuticals. Mr. Zilkha graduated cum laude from Princeton University.
- Richard A. Lechleiter
-
Richard A. Lechleiter,是一名注册会计师。从2002年2月到2014年1月,他担任Kindred Healthcare, Inc.(一家位于路易斯维尔(Louisville)的财富500强医疗服务公司)的执行副总裁兼首席财务官。Lechleiter先生也曾在其他大型上市的医疗服务公司担任高级财务职务,例如在他的职业生涯中有Humana Inc. 和 HCA, Inc.。他在财务报告、企业财务、投资者关系、并购以及公司治理方面拥有广泛的经验,对董事会极具价值。Lechleiter先生任职于审计委员会,担任一个金融专家,同时也是Bancorp的薪酬委员会主席。Lechleiter先生在2014年1月15日从Kindred退休。
Richard A. Lechleiter,is the President of the Catholic Education Foundation of Louisville. From February 2002 until his retirement in January 2014, he served as the Executive Vice President and Chief Financial Officer of Kindred Healthcare, Inc., a Fortune 500 healthcare services company based in Louisville. Mr. Lechleiter also served in senior financial positions at other large publicly held healthcare services companies such as Humana Inc. and HCA, Inc. during his professional financial career spanning nearly 35 years. His extensive experience in business leadership, financial reporting, corporate finance, investor relations, mergers and acquisitions and corporate governance is valuable to the Board. Mr. Lechleiter serves on the Audit Committee of Bancorp and has been designated by the Board of Directors as an audit committee financial expert. He also chairs the Compensation Committee of Bancorp. - Richard A. Lechleiter,是一名注册会计师。从2002年2月到2014年1月,他担任Kindred Healthcare, Inc.(一家位于路易斯维尔(Louisville)的财富500强医疗服务公司)的执行副总裁兼首席财务官。Lechleiter先生也曾在其他大型上市的医疗服务公司担任高级财务职务,例如在他的职业生涯中有Humana Inc. 和 HCA, Inc.。他在财务报告、企业财务、投资者关系、并购以及公司治理方面拥有广泛的经验,对董事会极具价值。Lechleiter先生任职于审计委员会,担任一个金融专家,同时也是Bancorp的薪酬委员会主席。Lechleiter先生在2014年1月15日从Kindred退休。
- Richard A. Lechleiter,is the President of the Catholic Education Foundation of Louisville. From February 2002 until his retirement in January 2014, he served as the Executive Vice President and Chief Financial Officer of Kindred Healthcare, Inc., a Fortune 500 healthcare services company based in Louisville. Mr. Lechleiter also served in senior financial positions at other large publicly held healthcare services companies such as Humana Inc. and HCA, Inc. during his professional financial career spanning nearly 35 years. His extensive experience in business leadership, financial reporting, corporate finance, investor relations, mergers and acquisitions and corporate governance is valuable to the Board. Mr. Lechleiter serves on the Audit Committee of Bancorp and has been designated by the Board of Directors as an audit committee financial expert. He also chairs the Compensation Committee of Bancorp.
- Julie D. Klapstein
-
Julie D. Klapstein是一名董事。她是Availity, LLC的创始首席执行官,这是全国最大的健康信息网络之一,优化医疗保健利益相关者之间关键业务和临床信息的自动交付。Klapstein女士从2001年到2011年担任Availity的首席执行官和董事会成员。从2017年2月到2017年6月,她担任Medical compensations of America, Inc.(一家私人公司)的临时首席执行官。Klapstein女士在医疗保健信息技术行业有30多年的经验,包括在Phycom, Inc.担任行政职务。1996年至2001年担任Sunquest Information Systems(执行副总裁)、Shared Medical Systems的交钥匙系统部门(现为Siemens Medical Systems)和GTE Health Systems的总裁兼首席执行官。她是Amedisys Inc.(纳斯达克股票代码:AMED)的董事,在那里她担任治理和质量委员会,并在那里她担任薪酬委员会主席;橡树街健康(纽约证券交易所代码:OSH),在那里她担任合规委员会和薪酬委员会主席;和MultiPlan Corporation(纽约证券交易所代码:MPLN),在那里她担任审计委员会成员。她目前还担任两家私人公司的董事会成员,包括专门从事收入周期管理解决方案的eSolutions, Inc.和专门从事医院复杂索赔的Revecore。Klapstein女士此前曾担任两家上市公司Annie’s Homegrown/Annies, Inc.的董事(2012年1月至2014年9月),她在治理、薪酬和审计委员会任职;2011年4月至2014年11月,她在治理、薪酬和审计委员会任职。她还曾担任多家私人公司的董事。她在俄勒冈州波特兰市(Portland, Oregon)的波特兰州立大学(Portland State University)获得学士学位。
Julie D. Klapstein,was the founding Chief Executive Officer of Availity, LLC (a private company), a health information network optimizing the automated delivery of critical business and clinical information among healthcare stakeholders. She served as Chief Executive Officer and as a board member of Availity from 2001 to 2012. She also served as the interim Chief Executive Officer of Revecore, a private company, from February 2017 to June 2017. Ms. Klapstein has more than 35 years of experience in the healthcare information technology industry including executive roles at healthcare companies including Phycom, Sunquest Information Systems, SMS' Turnkey Systems Division, and GTE Health Systems. Her early career with AT&T Information Systems also focused on the healthcare industry. Ms. Klapstein has served as a director of Amedisys, a public company, since 2016 and has served as its lead director since 2022. She also serves on the boards of several private companies including Omada Health, Aptarro, Unislink, and HCIM and is on the advisory boards of several private equity firms. In December 2023, Ms. Klapstein became a Partner Advisor to a16z. Ms. Klapstein served on the board of NextGen Healthcare from 2017 until November 2023, when it was acquired by Thoma Bravo and ceased being publicly-traded, Oak Street Health from 2020 until May 2023, when it was acquired by CVS and ceased being publicly-traded, and previously served on the boards of Annies, Inc. and Standard Register Co. She has also previously served on multiple private boards including eSolutions, a revenue cycle management company. - Julie D. Klapstein是一名董事。她是Availity, LLC的创始首席执行官,这是全国最大的健康信息网络之一,优化医疗保健利益相关者之间关键业务和临床信息的自动交付。Klapstein女士从2001年到2011年担任Availity的首席执行官和董事会成员。从2017年2月到2017年6月,她担任Medical compensations of America, Inc.(一家私人公司)的临时首席执行官。Klapstein女士在医疗保健信息技术行业有30多年的经验,包括在Phycom, Inc.担任行政职务。1996年至2001年担任Sunquest Information Systems(执行副总裁)、Shared Medical Systems的交钥匙系统部门(现为Siemens Medical Systems)和GTE Health Systems的总裁兼首席执行官。她是Amedisys Inc.(纳斯达克股票代码:AMED)的董事,在那里她担任治理和质量委员会,并在那里她担任薪酬委员会主席;橡树街健康(纽约证券交易所代码:OSH),在那里她担任合规委员会和薪酬委员会主席;和MultiPlan Corporation(纽约证券交易所代码:MPLN),在那里她担任审计委员会成员。她目前还担任两家私人公司的董事会成员,包括专门从事收入周期管理解决方案的eSolutions, Inc.和专门从事医院复杂索赔的Revecore。Klapstein女士此前曾担任两家上市公司Annie’s Homegrown/Annies, Inc.的董事(2012年1月至2014年9月),她在治理、薪酬和审计委员会任职;2011年4月至2014年11月,她在治理、薪酬和审计委员会任职。她还曾担任多家私人公司的董事。她在俄勒冈州波特兰市(Portland, Oregon)的波特兰州立大学(Portland State University)获得学士学位。
- Julie D. Klapstein,was the founding Chief Executive Officer of Availity, LLC (a private company), a health information network optimizing the automated delivery of critical business and clinical information among healthcare stakeholders. She served as Chief Executive Officer and as a board member of Availity from 2001 to 2012. She also served as the interim Chief Executive Officer of Revecore, a private company, from February 2017 to June 2017. Ms. Klapstein has more than 35 years of experience in the healthcare information technology industry including executive roles at healthcare companies including Phycom, Sunquest Information Systems, SMS' Turnkey Systems Division, and GTE Health Systems. Her early career with AT&T Information Systems also focused on the healthcare industry. Ms. Klapstein has served as a director of Amedisys, a public company, since 2016 and has served as its lead director since 2022. She also serves on the boards of several private companies including Omada Health, Aptarro, Unislink, and HCIM and is on the advisory boards of several private equity firms. In December 2023, Ms. Klapstein became a Partner Advisor to a16z. Ms. Klapstein served on the board of NextGen Healthcare from 2017 until November 2023, when it was acquired by Thoma Bravo and ceased being publicly-traded, Oak Street Health from 2020 until May 2023, when it was acquired by CVS and ceased being publicly-traded, and previously served on the boards of Annies, Inc. and Standard Register Co. She has also previously served on multiple private boards including eSolutions, a revenue cycle management company.
- Paul B. Kusserow
-
Paul B. Kusserow, 2014年12月以来,他是Amedisys, Inc.的总裁兼首席执行官,2014年12月加入Amedisys, Inc.以来,他一直是Amedisys, Inc.的董事会成员。此前,从2014年6月到2014年12月,他担任align Healthcare, Inc.(一家综合临床护理公司)的发展副董事长兼总裁。从2013年12月到2014年6月,他为医疗保健行业的公司和投资者提供执行咨询服务。在此之前,2009年2月至2013年8月,他担任Humana, Inc.(医疗保健服务和福利公司)的高级副总裁、首席战略、创新和企业发展官,并于2013年12月继续留在Humana, Inc.。在加入Humana, Inc.之前,他是Ziegler HealthVest基金的董事总经理兼首席投资官,该基金是一家风险投资基金,专注于医疗保健服务、医疗保健技术和健康的早期到中期投资;San Ysidro Capital Partners, l.l.c.的联合创始人兼董事总经理,这是一家专注于医疗保健服务和技术的投资咨询和管理公司;Roaring Mountain, L.L.C.(一家战略咨询公司,拥有医疗保健服务和技术方面的大客户)的管理合伙人。Kusserow先生在美国最大的投资者拥有的医疗服务公司之一Tenet healthcare Corporation开始了他的医疗保健职业生涯,在那里他度过了7年,最后4年担任战略和Tenet Ventures的高级副总裁。他曾任职于许多公司和咨询委员会,目前任职于Connecture, Inc., New Century Health, Inc.和Picwell, Inc.的董事会。他曾担任Availity Inc.的董事会主席。
Paul B. Kusserow is Amedisys, Inc.'s President and Chief Executive Officer since December 2014 and has been a member of Amedisys, Inc.'s Board of Directors since joining Amedisys, Inc. in December 2014. Previously, he was Vice Chairman and President, Development of Alignment Healthcare, Inc., an integrated clinical care company, from June 2014 until December 2014. From December 2013 until June 2014 Mr. Kusserow provided executive advisory services to companies and investors in the healthcare industry. Before that, he served as Senior Vice President, Chief Strategy, Innovations and Corporate Development Officer of Humana, Inc., a healthcare services and benefits company, from February 2009 through August 2013 and remained with Humana, Inc. through December 2013. Prior to joining Humana, Inc., he was Managing Director and Chief Investment Officer of the Ziegler HealthVest Fund, a venture capital fund focused on early to mid-stage investments in healthcare services, healthcare technology and wellness; a co-founder and Managing Director of San Ysidro Capital Partners, L.L.C., an investment advisory and management firm specializing in healthcare services and technology; and Managing Partner of Roaring Mountain, L.L.C., a strategy consulting firm with large clients in healthcare services and technology. Mr. Kusserow began his healthcare career with Tenet Healthcare Corporation, one of the nation's largest investor-owned healthcare service companies, where he spent seven years, the last four as Senior Vice President, Strategy and Tenet Ventures. He has served on many corporate and advisory boards, and currently serves on the Boards of Directors of Connecture, Inc., New Century Health, Inc., and Picwell, Inc. He previously served as the Chairman of the Board of Directors of Availity Inc. - Paul B. Kusserow, 2014年12月以来,他是Amedisys, Inc.的总裁兼首席执行官,2014年12月加入Amedisys, Inc.以来,他一直是Amedisys, Inc.的董事会成员。此前,从2014年6月到2014年12月,他担任align Healthcare, Inc.(一家综合临床护理公司)的发展副董事长兼总裁。从2013年12月到2014年6月,他为医疗保健行业的公司和投资者提供执行咨询服务。在此之前,2009年2月至2013年8月,他担任Humana, Inc.(医疗保健服务和福利公司)的高级副总裁、首席战略、创新和企业发展官,并于2013年12月继续留在Humana, Inc.。在加入Humana, Inc.之前,他是Ziegler HealthVest基金的董事总经理兼首席投资官,该基金是一家风险投资基金,专注于医疗保健服务、医疗保健技术和健康的早期到中期投资;San Ysidro Capital Partners, l.l.c.的联合创始人兼董事总经理,这是一家专注于医疗保健服务和技术的投资咨询和管理公司;Roaring Mountain, L.L.C.(一家战略咨询公司,拥有医疗保健服务和技术方面的大客户)的管理合伙人。Kusserow先生在美国最大的投资者拥有的医疗服务公司之一Tenet healthcare Corporation开始了他的医疗保健职业生涯,在那里他度过了7年,最后4年担任战略和Tenet Ventures的高级副总裁。他曾任职于许多公司和咨询委员会,目前任职于Connecture, Inc., New Century Health, Inc.和Picwell, Inc.的董事会。他曾担任Availity Inc.的董事会主席。
- Paul B. Kusserow is Amedisys, Inc.'s President and Chief Executive Officer since December 2014 and has been a member of Amedisys, Inc.'s Board of Directors since joining Amedisys, Inc. in December 2014. Previously, he was Vice Chairman and President, Development of Alignment Healthcare, Inc., an integrated clinical care company, from June 2014 until December 2014. From December 2013 until June 2014 Mr. Kusserow provided executive advisory services to companies and investors in the healthcare industry. Before that, he served as Senior Vice President, Chief Strategy, Innovations and Corporate Development Officer of Humana, Inc., a healthcare services and benefits company, from February 2009 through August 2013 and remained with Humana, Inc. through December 2013. Prior to joining Humana, Inc., he was Managing Director and Chief Investment Officer of the Ziegler HealthVest Fund, a venture capital fund focused on early to mid-stage investments in healthcare services, healthcare technology and wellness; a co-founder and Managing Director of San Ysidro Capital Partners, L.L.C., an investment advisory and management firm specializing in healthcare services and technology; and Managing Partner of Roaring Mountain, L.L.C., a strategy consulting firm with large clients in healthcare services and technology. Mr. Kusserow began his healthcare career with Tenet Healthcare Corporation, one of the nation's largest investor-owned healthcare service companies, where he spent seven years, the last four as Senior Vice President, Strategy and Tenet Ventures. He has served on many corporate and advisory boards, and currently serves on the Boards of Directors of Connecture, Inc., New Century Health, Inc., and Picwell, Inc. He previously served as the Chairman of the Board of Directors of Availity Inc.
- Linda J. Hall
-
Linda J. Hall,于2011年9月21日被任命为本公司的受托人。自2008年以来,一直担任明尼苏达大学卡尔森学院的管理企业家,目前她是创业公司和非盈利实体的顾问。作为密歇根大学的优等生毕业,拥有明尼苏达大学的博士学位。她曾担任公共和私营公司的行政职务,包括从2002年至2005年担任MinuteClinic的首席执行官。曾服务于多个公共和私人董事会,包括三家纳斯达克上市的公司,MTS Systems Corporation(自1995年至2006年8月),Technology(从2002年至2006年)和HealthFitness Corporation(从2001年到2010年)。除了担任受托人之外,目前担任Amedisys(纳斯达克股票代码:AMED),Ascension Health Ventures和Laastari/R-Clinic, Ltd.的董事。
Linda J. Hall has served as a trustee of the Company since September 21 2011. Since 2008 Ms. Hall has been a volunteer Entrepreneur-in-Residence at the Carlson School of Management, University of Minnesota. Ms. Hall has retired from her CEO role after 38 years of executive experience in the manufacturing and service sectors, including healthcare, venture capital financing, employee benefits, and teaching. During her career, she has launched 14 start-up companies as an executive, director, or consultant, including three inside $1 billion plus companies. Ms. Hall also has 23 years of experience serving on the boards of privately-held and public reporting companies in the United States and Europe, including serving as the chair of compensation, compliance, governance and nominating committees and as a member of audit committees. Ms. Hall currently serves on the boards of Amedisys NASDAQ: AMED, Ascension Ventures, and DentaQuest. She previously served on the boards of three publicly held companies: Health Fitness Corporation (NASDAQ: HFIT) from 2001 until it was acquired in 2010 MTS Systems Corporation (NASDAQ: MTS) from 1995 to 2006 and August Technology (NASDAQ: AUGT) from 2002 until it was acquired in 2006. She also previously served on the board of Laastari/R Clinic, a privately held European company, from 2010 to 2015. She is a Phi Beta Kappa graduate of the University of Michigan and received a Ph.D. from the University of Minnesota. - Linda J. Hall,于2011年9月21日被任命为本公司的受托人。自2008年以来,一直担任明尼苏达大学卡尔森学院的管理企业家,目前她是创业公司和非盈利实体的顾问。作为密歇根大学的优等生毕业,拥有明尼苏达大学的博士学位。她曾担任公共和私营公司的行政职务,包括从2002年至2005年担任MinuteClinic的首席执行官。曾服务于多个公共和私人董事会,包括三家纳斯达克上市的公司,MTS Systems Corporation(自1995年至2006年8月),Technology(从2002年至2006年)和HealthFitness Corporation(从2001年到2010年)。除了担任受托人之外,目前担任Amedisys(纳斯达克股票代码:AMED),Ascension Health Ventures和Laastari/R-Clinic, Ltd.的董事。
- Linda J. Hall has served as a trustee of the Company since September 21 2011. Since 2008 Ms. Hall has been a volunteer Entrepreneur-in-Residence at the Carlson School of Management, University of Minnesota. Ms. Hall has retired from her CEO role after 38 years of executive experience in the manufacturing and service sectors, including healthcare, venture capital financing, employee benefits, and teaching. During her career, she has launched 14 start-up companies as an executive, director, or consultant, including three inside $1 billion plus companies. Ms. Hall also has 23 years of experience serving on the boards of privately-held and public reporting companies in the United States and Europe, including serving as the chair of compensation, compliance, governance and nominating committees and as a member of audit committees. Ms. Hall currently serves on the boards of Amedisys NASDAQ: AMED, Ascension Ventures, and DentaQuest. She previously served on the boards of three publicly held companies: Health Fitness Corporation (NASDAQ: HFIT) from 2001 until it was acquired in 2010 MTS Systems Corporation (NASDAQ: MTS) from 1995 to 2006 and August Technology (NASDAQ: AUGT) from 2002 until it was acquired in 2006. She also previously served on the board of Laastari/R Clinic, a privately held European company, from 2010 to 2015. She is a Phi Beta Kappa graduate of the University of Michigan and received a Ph.D. from the University of Minnesota.
高管简历
中英对照 |  中文 |  英文- David Kemmerly
David Kemmerly,是我们的总法律顾问(2015年10月31日以来)、行政事务高级副总裁(2015年3月30日以来)。他此前曾担任临时总法律顾问(2015年3月30日至2015年10月30日)。他拥有25年以上的行政事务经验,并专注于医疗法律和公共政策17年。从2013年9月到2015年3月,他曾担任Adams and Reese LLP(多个学科相关的律师事务所)的特殊顾问,在那里他曾代表州立法机关和政府机构的多种医疗利益。任职Adams and Reese公司之前,他曾担任Humana, Inc的国家公共事务主任6年,在那里他负责所有50个州的立法和监管事务和产出。他开发和领导成功的国家立法和监管策略的实现,并帮助保护了全国最大的健康保险公司(有超过1300万个医疗注册)的商业利益。他拥有国家和国家政府的关系的丰富经验,包括担任the Louisiana State Medical Society的政府事务部门的副主任,在那里他曾游说州立法委员、国家监管机构,以及美国国会,涉及影响医生和医学的实践事务。他也曾担任路易斯安那州参议员的律师,以及DLK Consulting Group、各种各样的民选官员的办公室的政治顾问。
David Kemmerly is our General Counsel since October 31 2015 and Senior Vice President of Government Affairs (since March 30 2015). He previously served as Interim General Counsel from March 30 2015 to October 30 2015. Mr. Kemmerly has over 25 years of experience in governmental affairs, with more than 17 years specializing in health care law and public policy. From September 2013 to March 2015 he served as Special Counsel at Adams and Reese LLP, a multidisciplinary law firm where he represented diverse health care interests before the state legislature and state agencies. Prior to Adams and Reese, Mr. Kemmerly served as Director of State Public Affairs of Humana, Inc. for six years where he was responsible for legislative and regulatory affairs and outcomes in all 50 states. In this role, he developed and led implementation of successful state legislative and regulatory strategies that helped protect the business interests of one of the nation’s largest health insurers with over 13 million medical enrollees. Mr. Kemmerly has extensive experience in state and national government relations, including serving as the Louisiana State Medical Society’s Associate Director in the Department of Governmental Affairs where he lobbied state legislators, state regulatory agencies, and the U.S. Congress on issues impacting physicians and the practice of medicine. He also served as an attorney for the Louisiana State Senate, political consultant for DLK Consulting Group, and in the offices of various elected officials.- David Kemmerly,是我们的总法律顾问(2015年10月31日以来)、行政事务高级副总裁(2015年3月30日以来)。他此前曾担任临时总法律顾问(2015年3月30日至2015年10月30日)。他拥有25年以上的行政事务经验,并专注于医疗法律和公共政策17年。从2013年9月到2015年3月,他曾担任Adams and Reese LLP(多个学科相关的律师事务所)的特殊顾问,在那里他曾代表州立法机关和政府机构的多种医疗利益。任职Adams and Reese公司之前,他曾担任Humana, Inc的国家公共事务主任6年,在那里他负责所有50个州的立法和监管事务和产出。他开发和领导成功的国家立法和监管策略的实现,并帮助保护了全国最大的健康保险公司(有超过1300万个医疗注册)的商业利益。他拥有国家和国家政府的关系的丰富经验,包括担任the Louisiana State Medical Society的政府事务部门的副主任,在那里他曾游说州立法委员、国家监管机构,以及美国国会,涉及影响医生和医学的实践事务。他也曾担任路易斯安那州参议员的律师,以及DLK Consulting Group、各种各样的民选官员的办公室的政治顾问。
- David Kemmerly is our General Counsel since October 31 2015 and Senior Vice President of Government Affairs (since March 30 2015). He previously served as Interim General Counsel from March 30 2015 to October 30 2015. Mr. Kemmerly has over 25 years of experience in governmental affairs, with more than 17 years specializing in health care law and public policy. From September 2013 to March 2015 he served as Special Counsel at Adams and Reese LLP, a multidisciplinary law firm where he represented diverse health care interests before the state legislature and state agencies. Prior to Adams and Reese, Mr. Kemmerly served as Director of State Public Affairs of Humana, Inc. for six years where he was responsible for legislative and regulatory affairs and outcomes in all 50 states. In this role, he developed and led implementation of successful state legislative and regulatory strategies that helped protect the business interests of one of the nation’s largest health insurers with over 13 million medical enrollees. Mr. Kemmerly has extensive experience in state and national government relations, including serving as the Louisiana State Medical Society’s Associate Director in the Department of Governmental Affairs where he lobbied state legislators, state regulatory agencies, and the U.S. Congress on issues impacting physicians and the practice of medicine. He also served as an attorney for the Louisiana State Senate, political consultant for DLK Consulting Group, and in the offices of various elected officials.
- Larry R. Pernosky
Larry R. Pernosky,是我们的首席人力资源官(2015年4月21日以来)。2011年8月至2015年4月,他曾担任Humana, Inc.的人力资本咨询服务副总裁,在那里他曾担任多种职务(2004年以来),并协助推动领先的健康和福祉公司的关键人力资源操作效率。他十分了解首席运营官的管理团队,并负责人力资源业务领导团队、组织设计和改变做法、公司政策和实践、并购人力资源尽职调查和关联关系的协调和跨组织合作。任职Humana公司11年期间,他也曾领导并购、组织设计、人力资源政策、变更管理和通信沟通。
Larry R. Pernosky is our Chief Human Resources Officer since April 21 2015 and has over 30 years of experience leading human capital strategies to drive superior business outcomes. His expertise spans the health care, consumer goods manufacturing, petrochemical engineering, energy services, and media and entertainment industries. From August 2011 to April 2015 Mr. Pernosky served as Vice President of Human Capital Consulting for Humana, Inc., where he held various positions since 2004 and was instrumental in driving key human resources operational efficiencies for the leading health and well-being company. Working in close partnership with the Chief Operating Officer’s executive team, he was accountable for the coordination and cross-organizational collaboration of the HR Business Leadership team, Organizational Design and Change Practice, Company Policy and Practice, HR Due Diligence in Mergers and Acquisitions and Associate Relations. During his 11 years at Humana, he also led Organizational Design, HR M&A, Policy, Change Management and Associate Communications. Mr. Pernosky’s experience runs the gamut from Fortune 200 companies with global responsibilities to small, entrepreneurial start-up companies, including significant international experience. He has also held positions at Big Idea Productions, Inc., Halliburton Corporation, and Whirlpool Corporation.- Larry R. Pernosky,是我们的首席人力资源官(2015年4月21日以来)。2011年8月至2015年4月,他曾担任Humana, Inc.的人力资本咨询服务副总裁,在那里他曾担任多种职务(2004年以来),并协助推动领先的健康和福祉公司的关键人力资源操作效率。他十分了解首席运营官的管理团队,并负责人力资源业务领导团队、组织设计和改变做法、公司政策和实践、并购人力资源尽职调查和关联关系的协调和跨组织合作。任职Humana公司11年期间,他也曾领导并购、组织设计、人力资源政策、变更管理和通信沟通。
- Larry R. Pernosky is our Chief Human Resources Officer since April 21 2015 and has over 30 years of experience leading human capital strategies to drive superior business outcomes. His expertise spans the health care, consumer goods manufacturing, petrochemical engineering, energy services, and media and entertainment industries. From August 2011 to April 2015 Mr. Pernosky served as Vice President of Human Capital Consulting for Humana, Inc., where he held various positions since 2004 and was instrumental in driving key human resources operational efficiencies for the leading health and well-being company. Working in close partnership with the Chief Operating Officer’s executive team, he was accountable for the coordination and cross-organizational collaboration of the HR Business Leadership team, Organizational Design and Change Practice, Company Policy and Practice, HR Due Diligence in Mergers and Acquisitions and Associate Relations. During his 11 years at Humana, he also led Organizational Design, HR M&A, Policy, Change Management and Associate Communications. Mr. Pernosky’s experience runs the gamut from Fortune 200 companies with global responsibilities to small, entrepreneurial start-up companies, including significant international experience. He has also held positions at Big Idea Productions, Inc., Halliburton Corporation, and Whirlpool Corporation.
- Stephen Seim
Stephen Seim,2015年3月4日以来,他一直是我们的首席战略官。加入公司之前,他曾任职Humana18年,在那里他曾负责建设和领导公司战略团队。这个团队开发组织的总体战略以及战略识别和构建发展平台,用来多元化Humana公司的业务和构建综合保健交付模型。这项工作推动超过20亿美元的收购。他也领导医疗保险优势细分工作(这是一项来推动糖尿病患者服务适应的计划)、Humana公司的长期财务预测和资本的部署计划、医疗保险处方药业务。任职Humana公司之前,他曾担任Deloitte & Touche Consulting Group的经理,以及Ernst & Young的经理。
Stephen Seim is our Chief Strategy Officer since March 4 2015. In this role he is responsible for the Amedisys corporate strategy, mergers and acquisitions, and corporate business intelligence functions. Before joining the Company, Steve spent 18 years at Humana where he was responsible for building and leading their Corporate Strategy Team. This team developed the organization’s overall strategy as well as the strategies identifying and building the growth platforms used to diversify Humana’s business and build out their integrated care delivery model. This work drove over $2 billion in acquisitions. Mr. Seim also led Medicare Advantage segmentation work, an initiative to drive alignment around serving members with diabetes, Humana’s long term financial forecasting and capital deployment planning, and Medicare Prescription Drug operations. Prior to his work at Humana, Mr. Seim was a Manager at Deloitte & Touche Consulting Group and a Senior Consultant at Ernst & Young.- Stephen Seim,2015年3月4日以来,他一直是我们的首席战略官。加入公司之前,他曾任职Humana18年,在那里他曾负责建设和领导公司战略团队。这个团队开发组织的总体战略以及战略识别和构建发展平台,用来多元化Humana公司的业务和构建综合保健交付模型。这项工作推动超过20亿美元的收购。他也领导医疗保险优势细分工作(这是一项来推动糖尿病患者服务适应的计划)、Humana公司的长期财务预测和资本的部署计划、医疗保险处方药业务。任职Humana公司之前,他曾担任Deloitte & Touche Consulting Group的经理,以及Ernst & Young的经理。
- Stephen Seim is our Chief Strategy Officer since March 4 2015. In this role he is responsible for the Amedisys corporate strategy, mergers and acquisitions, and corporate business intelligence functions. Before joining the Company, Steve spent 18 years at Humana where he was responsible for building and leading their Corporate Strategy Team. This team developed the organization’s overall strategy as well as the strategies identifying and building the growth platforms used to diversify Humana’s business and build out their integrated care delivery model. This work drove over $2 billion in acquisitions. Mr. Seim also led Medicare Advantage segmentation work, an initiative to drive alignment around serving members with diabetes, Humana’s long term financial forecasting and capital deployment planning, and Medicare Prescription Drug operations. Prior to his work at Humana, Mr. Seim was a Manager at Deloitte & Touche Consulting Group and a Senior Consultant at Ernst & Young.
- Christopher T. Gerard
ChristopherT.Gerard自2017年1月3日起担任我们的首席运营官。他曾于2015年至2016年担任梦百合服务公司KindredHealthcare,Inc.的子公司Kindred At Home的中南部地区总裁。在担任区域总裁之前,Gerard先生于2014年至2015年担任Kindred At Home的首席运营官。Gerard先生于2012年加入Kindred,担任地区Vice President,当时Kindred收购了Integracare Holdings,Inc.,该公司是一家位于德克萨斯州葡萄园的家庭健康、临终关怀和社区护理机构。Gerard先生于1998年是IntegraCare的原始创始人,并于2007年至2012年担任其总裁兼首席执行官。
Christopher T. Gerard is our Chief Operating Officer since January 3 2017. He previously served as President for the South Central Region of Kindred at Home, a division of Kindred Healthcare, Inc., a healthcare services company, from 2015 to 2016. Prior to his role as Regional President, Mr. Gerard was the Chief Operating Officer at Kindred at Home from 2014 to 2015. Mr. Gerard joined Kindred in 2012 as Regional Vice President when Kindred acquired IntegraCare Holdings, Inc., a home health, hospice and community care agency based in Grapevine, Texas. Mr. Gerard was an original founder of IntegraCare in 1998 and served as its President and Chief Executive Officer from 2007 to 2012.- ChristopherT.Gerard自2017年1月3日起担任我们的首席运营官。他曾于2015年至2016年担任梦百合服务公司KindredHealthcare,Inc.的子公司Kindred At Home的中南部地区总裁。在担任区域总裁之前,Gerard先生于2014年至2015年担任Kindred At Home的首席运营官。Gerard先生于2012年加入Kindred,担任地区Vice President,当时Kindred收购了Integracare Holdings,Inc.,该公司是一家位于德克萨斯州葡萄园的家庭健康、临终关怀和社区护理机构。Gerard先生于1998年是IntegraCare的原始创始人,并于2007年至2012年担任其总裁兼首席执行官。
- Christopher T. Gerard is our Chief Operating Officer since January 3 2017. He previously served as President for the South Central Region of Kindred at Home, a division of Kindred Healthcare, Inc., a healthcare services company, from 2015 to 2016. Prior to his role as Regional President, Mr. Gerard was the Chief Operating Officer at Kindred at Home from 2014 to 2015. Mr. Gerard joined Kindred in 2012 as Regional Vice President when Kindred acquired IntegraCare Holdings, Inc., a home health, hospice and community care agency based in Grapevine, Texas. Mr. Gerard was an original founder of IntegraCare in 1998 and served as its President and Chief Executive Officer from 2007 to 2012.
- Scott G. Ginn
ScottG.Ginn自2017年2月起担任我们的首席会计官。他曾于2015年10月至2017年2月担任财务和会计高级副总裁,并于2007年4月至2015年10月担任会计和财务总监高级副总裁。加入公司之前,他曾担任Postlethwaite&Netterville公司(专业会计公司)的董事。Ginn先生是一名注册会计师。
Scott G. Ginn is our Chief Accounting Officer since February 2017. He previously served as Senior Vice President of Finance and Accounting from October 2015 to February 2017 and Senior Vice President of Accounting and Controller from April 2007 to October 2015. Prior to joining the Company, he was a Director at Postlethwaite & Netterville, a professional accounting corporation. Mr. Ginn is a Certified Public Accountant.- ScottG.Ginn自2017年2月起担任我们的首席会计官。他曾于2015年10月至2017年2月担任财务和会计高级副总裁,并于2007年4月至2015年10月担任会计和财务总监高级副总裁。加入公司之前,他曾担任Postlethwaite&Netterville公司(专业会计公司)的董事。Ginn先生是一名注册会计师。
- Scott G. Ginn is our Chief Accounting Officer since February 2017. He previously served as Senior Vice President of Finance and Accounting from October 2015 to February 2017 and Senior Vice President of Accounting and Controller from April 2007 to October 2015. Prior to joining the Company, he was a Director at Postlethwaite & Netterville, a professional accounting corporation. Mr. Ginn is a Certified Public Accountant.
- Michael P. North
MichaelP.North自2016年11月3日起担任我们的首席信息官,此前曾担任我们的运营高级副总裁(2015年5月11日至2016年11月3日)。North先生是一位经验丰富的IT高管,最近成功地领导了Amedisys向HomeCare HomeBase平台的转换。在Amedisys之前,他于2006年5月至2015年5月担任Humana的企业发展集成总监。他的高级职责包括收购的所有IT和运营集成。在此之前,North从1999年10月到2006年5月担任Kindred梦百合IT支持主管。
Michael P. North is our Chief Information Officer since November 3 2016 and previously served as our Senior Vice President of Operations (from May 11 2015 to November 3 2016). Mr. North, a seasoned IT executive, recently led Amedisys’ successful conversion to the Homecare Homebase platform. Before Amedisys, he served as the Director of Corporate Development Integrations for Humana from May 2006 to May 2015. His senior level responsibilities included all IT and operational integrations for acquisitions. Prior to that, North served as the Director of IT Support with Kindred Healthcare from October 1999 to May 2006.- MichaelP.North自2016年11月3日起担任我们的首席信息官,此前曾担任我们的运营高级副总裁(2015年5月11日至2016年11月3日)。North先生是一位经验丰富的IT高管,最近成功地领导了Amedisys向HomeCare HomeBase平台的转换。在Amedisys之前,他于2006年5月至2015年5月担任Humana的企业发展集成总监。他的高级职责包括收购的所有IT和运营集成。在此之前,North从1999年10月到2006年5月担任Kindred梦百合IT支持主管。
- Michael P. North is our Chief Information Officer since November 3 2016 and previously served as our Senior Vice President of Operations (from May 11 2015 to November 3 2016). Mr. North, a seasoned IT executive, recently led Amedisys’ successful conversion to the Homecare Homebase platform. Before Amedisys, he served as the Director of Corporate Development Integrations for Humana from May 2006 to May 2015. His senior level responsibilities included all IT and operational integrations for acquisitions. Prior to that, North served as the Director of IT Support with Kindred Healthcare from October 1999 to May 2006.
- David B. Pearce
DavidB.Pearce自2016年7月5日起担任首席合规官。Pearce先生将他的专业知识应用于管理和监督Amedisys的道德和合规计划。他负责制定和监督旨在促进道德行为和遵守联邦和州梦百合法律法规的政策、程序和做法。他还识别和评估组织内的任何合规漏洞和风险。在加入Amedisys之前,皮尔斯曾于2014年7月至2016年6月担任Kindred’;s(KND)at Home部门的高级副总裁兼首席法律顾问,该部门是一家价值25亿美元的家庭健康、临终关怀和社区护理服务企业,在全国约有700家分店,员工42000人。此前,Pearce从2010年9月到2013年7月担任Extendicare Health Services,Inc.(TSE:EXE)总法律顾问和首席合规官。Pearce从1999年10月到2010年8月担任Kindred梦百合医疗服务部门Vice President和首席法律顾问。他也曾担任Vencor公司(Kindred公司的前身)(从1998年12月到1999年10月)、肯塔基州列克星敦的Sturgill,Turner,Barker and Moloney律师事务所(从1994年6月到1998年12月)、亚特兰大的组织的总法律顾问、合规和法律职务,乔治亚州的律师事务所Arnall Golden and Gregory(从2013年7月到2014年7月)。他的法律职业生涯始于担任美国海军(the United States Navy)的参谋法官辩护律师,在那里他也曾担任两名高级军官的总法律顾问。Pearce先生在肯塔基大学(University of Kentucky)获得理学学士学位,并在北肯塔基大学(Northern Kentucky University)获得法学博士学位。
David B. Pearce is our Chief Compliance Officer since July 5 2016. Mr. Pearce applies his expertise to manage and oversee the ethics and compliance programs at Amedisys. He is responsible for developing and supervising policies, procedures and practices designed to promote ethical behavior and compliance with federal and state healthcare laws and regulations. He also identifies and assesses any compliance vulnerability and risk within the organization. Prior to joining Amedisys, Mr. Pearce served as Senior Vice President and Chief Counsel for Kindred’s (KND) at Home division, a $2.5 billion home health, hospice and community care services business with approximately 700 locations and 42000 employees nationwide, from July 2014 to June 2016. Previously, Mr. Pearce was General Counsel and Chief Compliance Officer for Extendicare Health Services, Inc. (TSE: EXE) from September 2010 to July 2013. Mr. Pearce served as Vice President and Chief Counsel for Kindred Healthcare’s Health Services Division from October 1999 to August 2010. He has also performed in general counsel, compliance, and legal roles for organizations such as Vencor (the predecessor to Kindred) (from December 1998 to October 1999), law firm Sturgill, Turner, Barker and Moloney in Lexington, Kentucky (from June 1994 to December 1998), and Atlanta, Georgia-based law firm Arnall Golden and Gregory (from July 2013 to July 2014). He began his legal career as a Staff Judge Advocate for the United States Navy, where he also served as general counsel for two high-ranking officers. Mr. Pearce received his Bachelor of Science degree from the University of Kentucky and earned his Juris Doctor from Northern Kentucky University.- DavidB.Pearce自2016年7月5日起担任首席合规官。Pearce先生将他的专业知识应用于管理和监督Amedisys的道德和合规计划。他负责制定和监督旨在促进道德行为和遵守联邦和州梦百合法律法规的政策、程序和做法。他还识别和评估组织内的任何合规漏洞和风险。在加入Amedisys之前,皮尔斯曾于2014年7月至2016年6月担任Kindred’;s(KND)at Home部门的高级副总裁兼首席法律顾问,该部门是一家价值25亿美元的家庭健康、临终关怀和社区护理服务企业,在全国约有700家分店,员工42000人。此前,Pearce从2010年9月到2013年7月担任Extendicare Health Services,Inc.(TSE:EXE)总法律顾问和首席合规官。Pearce从1999年10月到2010年8月担任Kindred梦百合医疗服务部门Vice President和首席法律顾问。他也曾担任Vencor公司(Kindred公司的前身)(从1998年12月到1999年10月)、肯塔基州列克星敦的Sturgill,Turner,Barker and Moloney律师事务所(从1994年6月到1998年12月)、亚特兰大的组织的总法律顾问、合规和法律职务,乔治亚州的律师事务所Arnall Golden and Gregory(从2013年7月到2014年7月)。他的法律职业生涯始于担任美国海军(the United States Navy)的参谋法官辩护律师,在那里他也曾担任两名高级军官的总法律顾问。Pearce先生在肯塔基大学(University of Kentucky)获得理学学士学位,并在北肯塔基大学(Northern Kentucky University)获得法学博士学位。
- David B. Pearce is our Chief Compliance Officer since July 5 2016. Mr. Pearce applies his expertise to manage and oversee the ethics and compliance programs at Amedisys. He is responsible for developing and supervising policies, procedures and practices designed to promote ethical behavior and compliance with federal and state healthcare laws and regulations. He also identifies and assesses any compliance vulnerability and risk within the organization. Prior to joining Amedisys, Mr. Pearce served as Senior Vice President and Chief Counsel for Kindred’s (KND) at Home division, a $2.5 billion home health, hospice and community care services business with approximately 700 locations and 42000 employees nationwide, from July 2014 to June 2016. Previously, Mr. Pearce was General Counsel and Chief Compliance Officer for Extendicare Health Services, Inc. (TSE: EXE) from September 2010 to July 2013. Mr. Pearce served as Vice President and Chief Counsel for Kindred Healthcare’s Health Services Division from October 1999 to August 2010. He has also performed in general counsel, compliance, and legal roles for organizations such as Vencor (the predecessor to Kindred) (from December 1998 to October 1999), law firm Sturgill, Turner, Barker and Moloney in Lexington, Kentucky (from June 1994 to December 1998), and Atlanta, Georgia-based law firm Arnall Golden and Gregory (from July 2013 to July 2014). He began his legal career as a Staff Judge Advocate for the United States Navy, where he also served as general counsel for two high-ranking officers. Mr. Pearce received his Bachelor of Science degree from the University of Kentucky and earned his Juris Doctor from Northern Kentucky University.
- Susan Sender
Susan Sender,RN,BSN,CHCE,自2016年8月29日起担任我们的首席临床运营官。Sender女士监督临床实践和质量,制定和维护临床操作标准,并开发和实施临床计划和临床教育。她还负责患者护理和质量结果的各个方面,并支持整个组织的临床医生。Sender女士在国内提供梦百合方面有30年的经验和专门知识。在加入Amedisys之前,她曾于2013年7月至2016年7月担任Kindred At Home(梦百合服务公司KindredHealthcare,Inc.的一个部门)的高级副总裁兼首席临床官,负责监督40个州的35000多名护士,治疗师,社会工作者和助手。她曾负责临床程序开发、政策制定、质量和性能改进、法规遵从性、临床分析和临床教育。Sender从2008年5月到2013年6月担任Loving Care Agency(新泽西一家家庭保健服务区域供应商)首席临床官和儿科业务Vice President。她的临床管理经验还包括在Gentiva工作23年,最后7年担任Vice President和首席护理执行官。她专门从事提高质量、临床实践、制定政策、减少不必要的住院,以及并购的临床方面。她曾任职于the U.S.Centers for Medicare&Medicaid Services(CMS)和the National Quality Forum的国家咨询委员会和小组。她持有纽约花园城Adelphi University的BSN。
Susan Sender, RN, BSN, CHCE, is our Chief Clinical Operations Officer since August 29 2016. Ms. Sender oversees clinical practice and quality, sets and maintains clinical operations standards and develops and implements clinical programs and clinical education. She is also responsible for every aspect of patient care and quality outcomes and support clinicians across the organization. Ms. Sender has 30 years of experience and expertise in the provision of healthcare at home. Prior to joining Amedisys, she served as Senior Vice President and Chief Clinical Officer at Kindred at Home, a division of Kindred Healthcare, Inc., a healthcare services company, from July 2013 to July 2016 overseeing more than 35000 nurses, therapists, social workers and aides across 40 states. She was responsible for clinical program development, policy development, quality and performance improvement, regulatory compliance, clinical analytics, and clinical education. From May 2008 to June 2013 Ms. Sender held Chief Clinical Officer and Vice President of Pediatric Operations positions for Loving Care Agency, a regional provider of home health services in New Jersey. Her experience in clinical management also encompasses 23 years at Gentiva, the last seven as Vice President and Chief Nursing Executive. She specializes in improving quality, clinical practice, developing policy, reducing unnecessary hospitalizations, and in the clinical aspects of Mergers and Acquisitions. She has served on national advisory boards and panels for the U.S. Centers for Medicare & Medicaid Services (CMS) and The National Quality Forum. She holds a BSN from Adelphi University in Garden City, New York.- Susan Sender,RN,BSN,CHCE,自2016年8月29日起担任我们的首席临床运营官。Sender女士监督临床实践和质量,制定和维护临床操作标准,并开发和实施临床计划和临床教育。她还负责患者护理和质量结果的各个方面,并支持整个组织的临床医生。Sender女士在国内提供梦百合方面有30年的经验和专门知识。在加入Amedisys之前,她曾于2013年7月至2016年7月担任Kindred At Home(梦百合服务公司KindredHealthcare,Inc.的一个部门)的高级副总裁兼首席临床官,负责监督40个州的35000多名护士,治疗师,社会工作者和助手。她曾负责临床程序开发、政策制定、质量和性能改进、法规遵从性、临床分析和临床教育。Sender从2008年5月到2013年6月担任Loving Care Agency(新泽西一家家庭保健服务区域供应商)首席临床官和儿科业务Vice President。她的临床管理经验还包括在Gentiva工作23年,最后7年担任Vice President和首席护理执行官。她专门从事提高质量、临床实践、制定政策、减少不必要的住院,以及并购的临床方面。她曾任职于the U.S.Centers for Medicare&Medicaid Services(CMS)和the National Quality Forum的国家咨询委员会和小组。她持有纽约花园城Adelphi University的BSN。
- Susan Sender, RN, BSN, CHCE, is our Chief Clinical Operations Officer since August 29 2016. Ms. Sender oversees clinical practice and quality, sets and maintains clinical operations standards and develops and implements clinical programs and clinical education. She is also responsible for every aspect of patient care and quality outcomes and support clinicians across the organization. Ms. Sender has 30 years of experience and expertise in the provision of healthcare at home. Prior to joining Amedisys, she served as Senior Vice President and Chief Clinical Officer at Kindred at Home, a division of Kindred Healthcare, Inc., a healthcare services company, from July 2013 to July 2016 overseeing more than 35000 nurses, therapists, social workers and aides across 40 states. She was responsible for clinical program development, policy development, quality and performance improvement, regulatory compliance, clinical analytics, and clinical education. From May 2008 to June 2013 Ms. Sender held Chief Clinical Officer and Vice President of Pediatric Operations positions for Loving Care Agency, a regional provider of home health services in New Jersey. Her experience in clinical management also encompasses 23 years at Gentiva, the last seven as Vice President and Chief Nursing Executive. She specializes in improving quality, clinical practice, developing policy, reducing unnecessary hospitalizations, and in the clinical aspects of Mergers and Acquisitions. She has served on national advisory boards and panels for the U.S. Centers for Medicare & Medicaid Services (CMS) and The National Quality Forum. She holds a BSN from Adelphi University in Garden City, New York.
- Gary D. Willis
Gary D. Willis自2008年5月起担任公司高级副总裁、总监和首席会计官。他从2006年2月到2008年5月担任LifePoint Hospitals, Inc.“LifePoint”(一家医院管理公司)高级副总裁和首席会计官。他从2002年12月到2006年2月担任LifePoint副总裁和总监。
Gary D. Willis is our Chief Financial Officer since January 3 2017. He previously served as the Executive Vice President and Chief Financial Officer of Capella Healthcare, a healthcare services company, from September 2015 through the date of its merger with RegionalCare Hospital Partners in May 2016. Prior to Capella, Mr. Willis served as the Chief Financial Officer of Martin Ventures, a healthcare venture capital firm, from March 2014 through September 2015. Prior to Martin Ventures, Mr. Willis served as the Senior Vice President and Chief Accounting Officer of Vanguard Health Systems, a healthcare services company, from 2008 through March 2014.- Gary D. Willis自2008年5月起担任公司高级副总裁、总监和首席会计官。他从2006年2月到2008年5月担任LifePoint Hospitals, Inc.“LifePoint”(一家医院管理公司)高级副总裁和首席会计官。他从2002年12月到2006年2月担任LifePoint副总裁和总监。
- Gary D. Willis is our Chief Financial Officer since January 3 2017. He previously served as the Executive Vice President and Chief Financial Officer of Capella Healthcare, a healthcare services company, from September 2015 through the date of its merger with RegionalCare Hospital Partners in May 2016. Prior to Capella, Mr. Willis served as the Chief Financial Officer of Martin Ventures, a healthcare venture capital firm, from March 2014 through September 2015. Prior to Martin Ventures, Mr. Willis served as the Senior Vice President and Chief Accounting Officer of Vanguard Health Systems, a healthcare services company, from 2008 through March 2014.
- Paul B. Kusserow
Paul B. Kusserow, 2014年12月以来,他是Amedisys, Inc.的总裁兼首席执行官,2014年12月加入Amedisys, Inc.以来,他一直是Amedisys, Inc.的董事会成员。此前,从2014年6月到2014年12月,他担任align Healthcare, Inc.(一家综合临床护理公司)的发展副董事长兼总裁。从2013年12月到2014年6月,他为医疗保健行业的公司和投资者提供执行咨询服务。在此之前,2009年2月至2013年8月,他担任Humana, Inc.(医疗保健服务和福利公司)的高级副总裁、首席战略、创新和企业发展官,并于2013年12月继续留在Humana, Inc.。在加入Humana, Inc.之前,他是Ziegler HealthVest基金的董事总经理兼首席投资官,该基金是一家风险投资基金,专注于医疗保健服务、医疗保健技术和健康的早期到中期投资;San Ysidro Capital Partners, l.l.c.的联合创始人兼董事总经理,这是一家专注于医疗保健服务和技术的投资咨询和管理公司;Roaring Mountain, L.L.C.(一家战略咨询公司,拥有医疗保健服务和技术方面的大客户)的管理合伙人。Kusserow先生在美国最大的投资者拥有的医疗服务公司之一Tenet healthcare Corporation开始了他的医疗保健职业生涯,在那里他度过了7年,最后4年担任战略和Tenet Ventures的高级副总裁。他曾任职于许多公司和咨询委员会,目前任职于Connecture, Inc., New Century Health, Inc.和Picwell, Inc.的董事会。他曾担任Availity Inc.的董事会主席。
Paul B. Kusserow is Amedisys, Inc.'s President and Chief Executive Officer since December 2014 and has been a member of Amedisys, Inc.'s Board of Directors since joining Amedisys, Inc. in December 2014. Previously, he was Vice Chairman and President, Development of Alignment Healthcare, Inc., an integrated clinical care company, from June 2014 until December 2014. From December 2013 until June 2014 Mr. Kusserow provided executive advisory services to companies and investors in the healthcare industry. Before that, he served as Senior Vice President, Chief Strategy, Innovations and Corporate Development Officer of Humana, Inc., a healthcare services and benefits company, from February 2009 through August 2013 and remained with Humana, Inc. through December 2013. Prior to joining Humana, Inc., he was Managing Director and Chief Investment Officer of the Ziegler HealthVest Fund, a venture capital fund focused on early to mid-stage investments in healthcare services, healthcare technology and wellness; a co-founder and Managing Director of San Ysidro Capital Partners, L.L.C., an investment advisory and management firm specializing in healthcare services and technology; and Managing Partner of Roaring Mountain, L.L.C., a strategy consulting firm with large clients in healthcare services and technology. Mr. Kusserow began his healthcare career with Tenet Healthcare Corporation, one of the nation's largest investor-owned healthcare service companies, where he spent seven years, the last four as Senior Vice President, Strategy and Tenet Ventures. He has served on many corporate and advisory boards, and currently serves on the Boards of Directors of Connecture, Inc., New Century Health, Inc., and Picwell, Inc. He previously served as the Chairman of the Board of Directors of Availity Inc.- Paul B. Kusserow, 2014年12月以来,他是Amedisys, Inc.的总裁兼首席执行官,2014年12月加入Amedisys, Inc.以来,他一直是Amedisys, Inc.的董事会成员。此前,从2014年6月到2014年12月,他担任align Healthcare, Inc.(一家综合临床护理公司)的发展副董事长兼总裁。从2013年12月到2014年6月,他为医疗保健行业的公司和投资者提供执行咨询服务。在此之前,2009年2月至2013年8月,他担任Humana, Inc.(医疗保健服务和福利公司)的高级副总裁、首席战略、创新和企业发展官,并于2013年12月继续留在Humana, Inc.。在加入Humana, Inc.之前,他是Ziegler HealthVest基金的董事总经理兼首席投资官,该基金是一家风险投资基金,专注于医疗保健服务、医疗保健技术和健康的早期到中期投资;San Ysidro Capital Partners, l.l.c.的联合创始人兼董事总经理,这是一家专注于医疗保健服务和技术的投资咨询和管理公司;Roaring Mountain, L.L.C.(一家战略咨询公司,拥有医疗保健服务和技术方面的大客户)的管理合伙人。Kusserow先生在美国最大的投资者拥有的医疗服务公司之一Tenet healthcare Corporation开始了他的医疗保健职业生涯,在那里他度过了7年,最后4年担任战略和Tenet Ventures的高级副总裁。他曾任职于许多公司和咨询委员会,目前任职于Connecture, Inc., New Century Health, Inc.和Picwell, Inc.的董事会。他曾担任Availity Inc.的董事会主席。
- Paul B. Kusserow is Amedisys, Inc.'s President and Chief Executive Officer since December 2014 and has been a member of Amedisys, Inc.'s Board of Directors since joining Amedisys, Inc. in December 2014. Previously, he was Vice Chairman and President, Development of Alignment Healthcare, Inc., an integrated clinical care company, from June 2014 until December 2014. From December 2013 until June 2014 Mr. Kusserow provided executive advisory services to companies and investors in the healthcare industry. Before that, he served as Senior Vice President, Chief Strategy, Innovations and Corporate Development Officer of Humana, Inc., a healthcare services and benefits company, from February 2009 through August 2013 and remained with Humana, Inc. through December 2013. Prior to joining Humana, Inc., he was Managing Director and Chief Investment Officer of the Ziegler HealthVest Fund, a venture capital fund focused on early to mid-stage investments in healthcare services, healthcare technology and wellness; a co-founder and Managing Director of San Ysidro Capital Partners, L.L.C., an investment advisory and management firm specializing in healthcare services and technology; and Managing Partner of Roaring Mountain, L.L.C., a strategy consulting firm with large clients in healthcare services and technology. Mr. Kusserow began his healthcare career with Tenet Healthcare Corporation, one of the nation's largest investor-owned healthcare service companies, where he spent seven years, the last four as Senior Vice President, Strategy and Tenet Ventures. He has served on many corporate and advisory boards, and currently serves on the Boards of Directors of Connecture, Inc., New Century Health, Inc., and Picwell, Inc. He previously served as the Chairman of the Board of Directors of Availity Inc.